Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Hydroxychloroquine (2-[[4-[(7-Chloroquinolin-4-yl)amino]pentyl](ethyl)amino]ethanol) (HCQ) is an alkalinizing lysosomatropic drug that acts by inducing apoptosis of renal cancer cells in vitro and inhibiting TLR7/9. It is a medication used to prevent and treat malaria, and it's also being studied as an experimental treatment for COVID-19.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
50 mg | 在庫あり | ¥ 7,000 | |||
100 mg | 在庫あり | ¥ 9,000 | |||
200 mg | 在庫あり | ¥ 13,000 | |||
500 mg | 在庫あり | ¥ 21,000 |
説明 | Hydroxychloroquine (2-[[4-[(7-Chloroquinolin-4-yl)amino]pentyl](ethyl)amino]ethanol) (HCQ) is an alkalinizing lysosomatropic drug that acts by inducing apoptosis of renal cancer cells in vitro and inhibiting TLR7/9. It is a medication used to prevent and treat malaria, and it's also being studied as an experimental treatment for COVID-19. |
別名 | 2-[[4-[(7-Chloroquinolin-4-yl)amino]pentyl](ethyl)amino]ethanol |
分子量 | 335.87 |
分子式 | C18H26ClN3O |
CAS No. | 118-42-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
H2O: 1.65 mg/mL (4.91 mM), Sonication and heating to 60℃ are recommended.
DMSO: < 1 mg/mL (insoluble or slightly soluble)
1M HCl: 99 mg/mL (294.75 mM), when pH is adjusted to 2 with HCl.
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Hydroxychloroquine 118-42-3 Autophagy Immunology/Inflammation Microbiology/Virology SARS-CoV TLR Parasite Toll-like Receptor (TLR) Inhibitor 2-[[4-[(7-Chloroquinolin-4-yl)amino]pentyl](ethyl)amino]ethanol SARS coronavirus inhibit inhibitor